VISTAGEN THERAPEUTICS, INC. Foreign Currency Transaction Gain, before Tax
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Foreign Currency Transaction Gain, before Tax of -$22.00 thousand for the 9-month period ending 2014-12-31, per its 10-Q filed 2015-02-17.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionGainBeforeTax · last filed 2015-02-17
- 2014-12-31: Foreign Currency Transaction Gain, before Tax 9 month -$22.00K.
- 2013-12-31: Foreign Currency Transaction Gain, before Tax 9 month -$30.10K.
| Period end | Foreign Currency Transaction Gain, before Tax 9 month |
|---|---|
| 2014-12-31 | -$22.00K 10-Q · filed 2015-02-17 |
| 2013-12-31 | -$30.10K 10-Q · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |